Vortex Biosciences, Inc.

A major development is underway in the South London borough of Sutton, with the £1bn London Cancer Hub project poised to create significant opportunities for biotech companies focused on oncology rese

Vortex Biosciences Inc. , which specializes in circulating tumor cell harvesting for cancer diagnostics, has promoted Chief Technology Officer Bob Englert to the role of Chief Executive Officer. Engle

Device Debuts is a regular Medtech Insight feature highlighting new products introduced into the market for the first time, important new iterations of existing products, or launches of existing pro

Device Debuts highlights brand new products introduced into the market for the first time, as well as important new iterations of existing products, or important product introductions into new geograp